Skip to content

Adapted Physical Activity Effect on Abilities and Quality of Life of Huntington Patients and Relatives During Rehab Stay

Effect of Adapted Physical Activity, During Rehabilitation Stay, on Abilities and Quality of Life of Huntington Patients and Their Relatives HUNT'ACTIV-MH-REHAB MOVE MORE TO LIVE BETTER

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04917133
Acronym
HUNT'ACTIV
Enrollment
32
Registered
2021-06-08
Start date
2021-06-07
Completion date
2021-12-07
Last updated
2022-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington Disease

Keywords

Adapted Physical Activity, Huntington's disease, rehabilitation

Brief summary

Intro: Huntington's disease is a neurodegenerative disease that affects the brain, inducing a dysfunction and death of the middle spiny striatal projection neurons and a progressive alteration of cognitive and motor functions, and psycho-behavioral problems. There is currently no curative treatment but we know hat a multidisciplinary care can optimize the functioning and the quality of life of the patients with Huntington's disease. A meta-analysis of 18studies indicates that exercise and physical activity can improve motor function, gait speed and balance, and would also improve self-confidence, independence, well-being, reduced apathy and better socialization with family and friends. Hypothesis/Objective The hypothesis is that the inclusion of a 4 week-program with Adapted Physical Activity (APA) during a rehabilitation stay will improve some motor, cognitive and psycho-behavioral abilities, compared to the control group. Method The patients will be randomized into two groups : The control group will have the classic program performed in the standard of care with: kinesitherapy, soft gym, medico-social workshop, cognitive workshop, creative workshop, individual care (rehabilitation, rest, and creation). The experimental APA group will have in addition of the classic program, 6 APA workshops per week with collective support : Adapted Physical workshops, adapted cycling, therapeutic (horseback/equestrian) riding, cultural or leisure outings, situation tests For the two groups, at the start of the 4 weeks of rehabilitation program an initial visit will be performed with, as part of this research, a clinical examination, a neurological examination, a dietary consultation, as well as a biological assessment as part of habitual care. The clinical examination, the neurological examination and the dietary consultation will be performed each week, during the 4 weeks of the program, At the end of the study, one month after the rehabilitation of the patient, a visit by phone-call will be performed for the patient and his caregiver.

Interventions

classic 4-week rehabilitation program (standard care) + 6 APA workshops per week with collective care

OTHERControl

classic 4-week rehabilitation program (standard care)

Sponsors

Euromov Digital Health in Motion Montpellier France
CollaboratorUNKNOWN
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

controlled randomized trial with two parallel arms

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for the Patient : * Mid-stage Huntington's disease but with the ability for an autonomous walking for 10 meter * Age ≥ 18 years old * Stable medication for at least 4 weeks before the start of the study and a stable diet during the duration of the program. A stable diet means no weight loss up to 2kg in the last month prior to inclusion * Patient who received a complete information and who signed an informed consent for the research (or his/her caregiver if incapacity to sign). Tutor/Guardian who received a complete information and who signed an informed consent for the research if applicable * Affiliated to a social security scheme Inclusion Criteria for the Caregiver : * Person participating in the daily life of the patient * The patient is included in the research * Age ≥ 18 years old * Having received a complete information * Non opposition collected by the investigator

Exclusion criteria

* Having a physical or psychiatric condition preventing the completion of the program and assessments. * Having a history of additional major neurological disorders such as a stroke or an orthopedic condition limiting mobility * Any difficulty to understand or read French which could possibly invalidate the relevance of the application of questionnaires according to the opinion of the investigator * Addictions, alcohol dependence * Any other neurological, musculoskeletal or cardiovascular disease which could lead to errors in the assessment * Participation to another interventional research or being in the exclusion period following a previous research if applicable * Patient under AME (except if exemption from affiliation)

Design outcomes

Primary

MeasureTime frameDescription
Motor function score of Unified Huntington's Disease Rating Scale (UHDRS)Change from Baseline at 1 monthUHDRS:Unified Huntington's Disease Rating Scale , minimum value: 0 maximum value: 124 higher score means a worse outcome Success will be defined by an improvement of the motor function score

Secondary

MeasureTime frameDescription
cognitive function score of Unified Huntington's Disease Rating Scale (UHDRS) using Stroop testChange from Baseline at 1 monthUHDRS:Unified Huntington's Disease Rating Scale , minimal number of correct answers:0 maximal number of correct answers:100 higher score means a better outcome Success will be defined by an improvement of the cognitive function score
psycho-behavioral function score of Unified Huntington's Disease Rating Scale (UHDRS)Change from Baseline at 1 monthUHDRS:Unified Huntington's Disease Rating Scale , minimum value:0 maximal value:88 higher score means a worse outcome Success will be defined by an improvement of the behavioral function score

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026